Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

Spinal Cord Neoplasm Clinical Trial

Official title:
Validation of Pre-Clinical Nano-Based Analgesics in Cells From Dorsal Root Ganglia

Status Recruiting

Clinical Trial Summary

This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.

Clinical Trial Description

PRIMARY OBJECTIVE: I. To identify translational mechanisms and therapeutics for neuropathic pain, a type of chronic pain that can arise due to injured nerves. OUTLINE: Patients' leftover dorsal root ganglia samples are collected during standard of care surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04533919
Study type	Observational
Source	M.D. Anderson Cancer Center
Contact	Andrew J. Shepherd
Phone	713-745-7959
Email	ajshepherd@mdanderson.org
Status	Recruiting
Phase
Start date	June 16, 2020
Completion date	April 30, 2025

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04219969` - FDG PET-MRI for the Diagnosis of Spinal Cord Lesions	N/A
	Completed	`NCT00100802` - Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas	Phase 2